Regular paper
Characterization of the human dopamine D3 receptor expressed in transfected cell lines

https://doi.org/10.1016/0922-4106(94)90212-7Get rights and content

Abstract

A full-length cDNA clone of the human dopamine D3 receptor was obtained by the polymerase chain reaction (PCR) using reverse-transcribed RNA from human brain as the template. The cDNA was inserted into an expression vector which was then stably transfected into either Chinese hamster ovary (CHO), SK-N-MC human epithelioma or mouse CCL1.3 fibroblast cell lines. Post-transfection, the Bmax or D3 receptor expression was 1.9, 1.1 and 0.4 pmol/mg protein in the CHO-K1, SK-N-MC and CCL1.3 cell lines, respectively. The D3 receptor expressed in CHO-K1 and CCL1.3 cells exhibited similar radioligand binding profiles, especially for the D3-selective compound, 7-hydroxy-2-(di-n-propylamino)tetralin (7-OH-DPAT). Radioligand-binding competition curves of presumed D3 agonists were shifted to the right by the addition of guanine nucleotides and Na+ to the assay buffer. Presumed D3-receptor agonists had no effect on cAMP accumulation in any of the D3-transfected cell lines although cAMP accumulation was inhibited by dopamine D2 receptor activation in D2-transfected CHO and CCL1.3 cells and by activation of the exogenously expressed neuropeptide Y receptor in SK-N-MC cells. Also, D3 receptor activation neither potentiated ATP-stimulated arachidonic acid release from CHO cells nor stimulated inositol phosphate production in CCL1.3-cells although both of these responses were elicited by D2 agonists in D2-transfected cells. We conclude that the signalling properties of the D3 receptor differ from those of its closest homolog, the D2 receptor.

References (23)

  • C.C. Felder et al.

    A transduction pathway associated with receptors coupled to the inhibitory guanine nucleotide binding protein Gi that amplifies ATP-mediated arachidonic acid release

  • Cited by (108)

    • Analgesia and pain: Dual effect of dopamine on the peripheral nociceptive system is dependent on D<inf>2</inf>-or D<inf>1</inf>–like receptor activation

      2022, European Journal of Pharmacology
      Citation Excerpt :

      This event suggests differences in intracellular signalling mediated by each type of receptor, such as the level of inhibition of the adenylate cyclase enzyme. For example, D3 receptors do not or weakly inhibit adenylate cyclase enzyme, depending on the type of cell line evaluated, as reported in some previous studies (Chio et al., 1994; Freedman et al., 1994; MacKenzie et al., 1994; Tang et al., 1994; Robinson and Caron, 1996). Although dopamine D1-like receptors are expressed in greater quantities than D2-like receptors, these have high affinity and are activated by lower concentrations of dopamine (Paulus and Trenkwalder, 2006).

    • Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent

      2015, Bioorganic and Medicinal Chemistry
      Citation Excerpt :

      Displacement of [3H]-SCH23 390, [3H]-prazosin, [3H]-RX 821 002 and [3H]-4-DAMP evaluated in CHO cells which stably expressed the human D1, α1, α2C and M3 receptors. In case of human 5-HT6/7 and D2/3/4 receptors stably expressed in CHO cells, [3H]-LSD and [3H]-methyl-spiperone were used, respectively.20–22 The in vitro functional activity of two selected compounds 10 and 14 on intracellular cAMP/IP1/Ca2+ release levels, studied in CHO or HEK-293 cells which stably expressed the human 5-HT1A/2A/2C/6/7, α1/2C, H1 and D1/2/3/4 receptors, was determined at Cerep (Le Bois l’Eveque, 86600 Celle L’Evescault, France) according to the previously published methods (Table 3).20–23

    View all citing articles on Scopus
    View full text